DUBLIN, Oct. 28, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/7jdr38/2016_world_tumor) has announced the addition of the "2016 World Tumor Marker and Special Chemistry Testing Market: Supplier Shares, Competitive Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review" report to their offering.
This new report provides analysis of the global tumor markers and special chemistry testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays:
- CA 15-3/27-29
- CA 19-9
- Follate (Folic Acid)
- Glycosylated Hemoglobin
- 25-Hydroxy Vitamin D2 and D3
- Occult Blood
- Vitamin B-12
During the next decade, the tumor markers and special chemistry testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
2016 World Tumor Marker and Special Chemistry Testing Market: Supplier Shares, Competitive Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major assays; compares features of leading analyzers; and profiles key competitors.
- Beckman Coulter/Danaher
- Becton Dickinson
- CellMark Forensics/LabCorp
- Ortho-Clinical Diagnostic
- Proteome Sciences
- Thermo Fisher/Life Technologies
For more information visit http://www.researchandmarkets.com/research/7jdr38/2016_world_tumor
Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets